[HTML][HTML] Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib: implications for the treatment of HER2-positive and …
DM Collins, NT Conlon, S Kannan, CS Verma, LD Eli… - Cancers, 2019 - mdpi.com
… This review focuses on preclinical findings regarding … -depth and comprehensive review of
preclinical data. Clinical trials … Despite their similarities, multiple distinguishing characteristics …
preclinical data. Clinical trials … Despite their similarities, multiple distinguishing characteristics …
Experimental breast cancer models: preclinical imaging perspective
… The advantages and disadvantages of the use of small animals in the preclinical breast
cancer … Therefore, when selecting a model for the preclinical study, these characteristics of the …
cancer … Therefore, when selecting a model for the preclinical study, these characteristics of the …
A new model of patient tumor-derived breast cancer xenografts for preclinical assays
E Marangoni, A Vincent-Salomon, N Auger… - Clinical cancer …, 2007 - AACR
… Therefore, a preclinical model of breast cancer must be … Such a model of breast cancers
could identify new therapeutic … that breast cancer xenografts conserve the characteristics of …
could identify new therapeutic … that breast cancer xenografts conserve the characteristics of …
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression
JJ Arroyo‐Crespo, A Armiñán… - … journal of cancer, 2019 - Wiley Online Library
… preclinical models that faithfully reproduce the clinical scenario. We describe two preclinical
… cancer cells for lipids and cholesterol,34 a characteristic now considered a hallmark of …
… cancer cells for lipids and cholesterol,34 a characteristic now considered a hallmark of …
Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer
NP Núñez, D Jelovac, L Macedo, D Berrigan… - Clinical cancer …, 2004 - AACR
… breast cancer cell growth and increased BMD but caused uterine hypertrophy in this preclinical
model of postmenopausal breast cancer… risk of endometrial cancer risk and osteoporosis) …
model of postmenopausal breast cancer… risk of endometrial cancer risk and osteoporosis) …
Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer
T Fujii, G Yokoyama, H Takahashi, R Namoto… - Breast cancer, 2008 - Springer
… To clarify the role of PKC in the breast cancer cell, we have … the cell cycle by treating the
breast cancer cell line SKBR-3 with … characteristics through HER2-dependent pathways in breast …
breast cancer cell line SKBR-3 with … characteristics through HER2-dependent pathways in breast …
Screening for preclinical disease: test and disease characteristics
CR Herman, HK Gill, J Eng… - American journal of …, 2002 - Am Roentgen Ray Soc
… Diagnosing and treating breast cancer during the preclinical phase result in a higher … 5-year
patient survival rate than when breast cancer is diagnosed during the clinical phase [14]. …
patient survival rate than when breast cancer is diagnosed during the clinical phase [14]. …
[HTML][HTML] Antitumor properties of curcumin in breast cancer based on preclinical studies: a systematic review
KA Barcelos, CR Mendonça, M Noll, AF Botelho… - Cancers, 2022 - mdpi.com
… breast cancer reported in preclinical in vitro and in vivo animal models. We used five databases
to search for preclinical … Characteristics of the in vitro studies included in the systematic …
to search for preclinical … Characteristics of the in vitro studies included in the systematic …
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer
V Stearns, T Mori, LK Jacobs, NF Khouri… - Science translational …, 2011 - science.org
… ) in two preclinical … preclinical studies, we also initiated a phase 1 clinical trial to establish
the logistics of intraductal administration in an outpatient setting to women with breast cancer …
the logistics of intraductal administration in an outpatient setting to women with breast cancer …
[HTML][HTML] Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
… that have stem cell-like characteristics, and CD44–CD24+ … breast cancer cell types and
identify targets such as JAK2 and Stat3 that may lead to more specific and effective breast cancer …
identify targets such as JAK2 and Stat3 that may lead to more specific and effective breast cancer …
相关搜索
- breast cancer preclinical tumor model
- breast cancer preclinical and clinical evaluation
- triple negative breast cancer
- breast cancer cells
- breast cancer preclinical studies
- animal models of breast cancer
- her2 positive breast cancer
- early stage breast cancer
- xenograft models of breast cancer
- human breast cancer
- breast cancers box binding protein 1
- breast cancer clinical efficacy
- breast cancer mouse models
- breast cancer prevention
- breast cancer subtypes preclinical models
- patients with her2 advanced breast cancer